Etiology, Prevention and Therapy Navigation of Cancer

Overview

Información sobre este estudio

The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in “real world” practice conditions.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria - Group A Germline and Somatic Testing:

  • Has Mayo Clinic medical record number.
  • Confirmed cancer diagnosis which is either recurrent, relapsed, refractory, metastatic, or advanced.
  • Participant aware of cancer diagnosis.
  • Able to provide informed consent.
  • ≥ 18 years old.
  • Ability to provide blood, saliva, bone marrow aspirate or hair follicle sample.
  • Ability to provide archived tissue.
    • NOTE: if tissue unavailable participant may still enroll onto the study for the germline collection.

Exclusion Criteria:

  • Individuals who have situations that would limit compliance with the study requirements.
  • Institutionalized (i.e., Federal Medical Prison).
  • Prior germline genetic testing with a 100+ multi-gene panel within the last 1 year of enrollment AND/OR
  • Prior somatic tissue (250+ gene) testing within the prior 3 months of enrollment.
    • NOTE: Women, who are pregnant, or planning to become pregnant, can take part in this study.

Inclusion Criteria - Group B Germline Testing Only:

  • Has Mayo Clinic medical record number.
  • Confirmed cancer diagnosis.
  • Participant aware of cancer diagnosis.
  • Able to provide informed consent.
  • ≥ 18 years old.
  • Ability to provide blood, saliva, or hair follicle sample.

Exclusion Criteria:

  • Individuals who have situations that would limit compliance with the study requirements.
  • Institutionalized (i.e. Federal Medical Prison).
  • Prior germline genetic testing with a 100+ multi-gene panel within the last 1 year of enrollment.

Eligibility last updated 12/28/23. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Mrinal Patnaik, M.B.B.S.

Abierto para la inscripción

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Jeremy Jones, M.D.

Abierto para la inscripción

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Scottsdale/Phoenix, Ariz.

Investigador principal de Mayo Clinic

Niloy Jewel Samadder, M.D.

Abierto para la inscripción

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publicaciones

Publications are currently not available
.
CLS-20547957

Mayo Clinic Footer